RecruitingNot ApplicableNCT05948904

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.


Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

200 participants

Start Date

Nov 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Developing a standardized methodology for the use of novel cryogenic catheters for transbronchial cryobiopsy and cryoablation of pulmonary lesions.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients undergoing lung transplant surgery

Exclusion Criteria2

  • Organ donor ineligible to donate lungs
  • Healthy individuals

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCryo Ex Vivo

Lungs from patients undergoing lung transplantation after their removal from the recipient patient with previous informed consent signed before transplantation will be obtained. The organs will be placed in an acrylic box and will be kept at a temperature of 37 Celsius degrees. The lungs will be mechanically ventilated connected by an endotracheal tube size 8 inserted in the bronchus with the balloon inflated and a silk suture providing a hermetic closure proximal to the balloon. Tissue samples will be taken from the models and images will be performed.


Locations(1)

CHUM

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05948904


Related Trials